ITGB1 and breast cancer: The BC-MSCs expressed the same surface antigens as human BM-MSCs, and they were positive for CD13, CD29, CD44, CD105 and HLA-I, but negative for CD4, CD10, CD14, CD31, CD34, CD38 and HLA-DR.